CVRx, Inc.
CVRx, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 65 | 72 | 76 | 85 | 95 | 103 | 106 | 100 | 70 | 80 | 91 | 83 | |||||
Accounts Receivable Net Current | 9 | 9 | 11 | 8 | 7 | 9 | 9 | 9 | 9 | 8 | 8 | 6 | |||||
Inventory Net | 13 | 12 | 12 | 11 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | 11 | |||||
Prepaid Expense And Other Assets Current | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | |||||
Assets Current | 89 | 97 | 102 | 108 | 116 | 126 | 130 | 124 | 92 | 102 | 112 | 104 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 92 | 100 | 105 | 111 | 120 | 130 | 133 | 128 | 96 | 106 | 115 | 106 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 2 | 1 | |||||
Accrued Liabilities Current | 7 | 6 | 9 | 8 | 7 | 6 | 8 | 8 | 6 | 6 | 6 | 6 | |||||
Liabilities Current | 11 | 9 | 13 | 11 | 10 | 9 | 11 | 11 | 9 | 8 | 8 | 7 | |||||
Long Term Debt Noncurrent | 59 | 58 | 50 | 49 | 49 | 49 | 49 | 49 | 29 | 29 | 29 | 14 | |||||
Operating Lease Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 72 | 71 | 65 | 63 | 62 | 60 | 62 | 62 | 41 | 40 | 39 | 24 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 638 | 633 | 630 | 627 | 624 | 620 | 608 | 592 | 569 | 566 | 553 | 551 | |||||
Retained Earnings Accumulated Deficit | -618 | -604 | -591 | -579 | -566 | -551 | -537 | -527 | -514 | -500 | -477 | -468 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | 20 | 29 | 39 | 48 | 58 | 69 | 71 | 65 | 55 | 66 | 76 | 83 | |||||
Liabilities And Stockholders Equity | 92 | 100 | 105 | 111 | 120 | 130 | 133 | 128 | 96 | 106 | 115 | 106 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 27 | 26 | 26 | 26 | 26 | 26 | 25 | 24 | 22 | 22 | 21 | 21 | |||||
Shares Outstanding | 27 | 26 | 26 | 26 | 26 | 26 | 25 | 24 | 22 | 22 | 21 | 21 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.09% | 6.26% | -1.80% | - | - | - | - | - | - | - | - | - |
| 2025 | 39.10% | 22.01% | 74.84% | 15.36% | 10.95% | 53.56% | -2.39% | -26.17% | -27.26% | 66.67% | 82.02% | 61.01% |
| 2024 | -4.40% | 64.92% | 32.19% | 6.08% | 10.69% | 15.31% | 10.82% | -9.63% | 31.49% | -23.63% | -58.41% | -68.16% |
| 2023 | - | - | - | - | - | - | 49.63% | 86.77% | 98.28% | -14.69% | -25.28% | -39.72% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 8.04 | 10.20 | 7.63 | 9.62 | 11.99 | 14.83 | 12.06 | 11.32 | 10.08 | 12.18 | 14.25 | 13.99 | |||||
| Quick Ratio | 6.65 | 8.58 | 6.49 | 8.32 | 10.55 | 13.13 | 10.70 | 9.97 | 8.66 | 10.55 | 12.48 | 12.06 | |||||
| Working Capital | 78.36M | 87.26M | 88.33M | 96.67M | 106.46M | 117.63M | 119.05M | 112.93M | 82.87M | 93.92M | 104.23M | 96.19M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.63 | 2.43 | 1.66 | 1.32 | 1.06 | 0.87 | 0.88 | 0.96 | 0.74 | 0.60 | 0.52 | 0.28 | |||||
| Interest Coverage TTM | -8.07 | -8.44 | -8.80 | -8.49 | -9.45 | -10.36 | -13.53 | -17.04 | -18.48 | -21.11 | -23.96 | -32.43 | |||||
| Debt Ratio | 0.78 | 0.71 | 0.62 | 0.57 | 0.52 | 0.46 | 0.47 | 0.49 | 0.42 | 0.38 | 0.34 | 0.22 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.58 | 0.52 | 0.48 | 0.47 | 0.51 | 0.45 | 0.41 | 0.40 | 0.42 | 0.37 | 0.33 | 0.30 | |||||
| Days Sales Outstanding TTM | 49.37 | 55.97 | 64.21 | 56.22 | 52.62 | 60.43 | 59.84 | 59.49 | 63.03 | 64.74 | 60.63 | 60.56 | |||||
| Receivables Turnover TTM | 7.39 | 6.52 | 5.68 | 6.49 | 6.94 | 6.04 | 6.10 | 6.14 | 5.79 | 5.64 | 6.02 | 6.03 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.96 | -2.00 | -2.04 | -1.99 | -2.00 | -1.99 | -2.65 | -2.57 | -2.51 | -2.45 | -1.99 | -2.05 | |||||
| Free Cash Flow Per Share TTM | -1.57 | -1.52 | -1.56 | -1.00 | -1.02 | -1.61 | -1.79 | -1.78 | -1.76 | -1.93 | -1.91 | -2.04 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 86.92% | 86.18% | 85.33% | 84.49% | 83.54% | 83.44% | 83.75% | 84.16% | 84.40% | 84.45% | 84.08% | 82.81% | |||||
| Operating Profit Margin TTM | -79.49% | -84.62% | -90.49% | -89.97% | -93.50% | -95.89% | -115.98% | -124.59% | -124.78% | -126.34% | -109.69% | -127.74% | |||||
| Net Profit Margin TTM | -84.93% | -89.15% | -94.10% | -92.95% | -95.61% | -97.49% | -116.91% | -123.75% | -122.52% | -123.58% | -104.85% | -121.06% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 11.96% | 11.73% | 10.45% | 18.44% | 23.11% | 25.62% | 30.53% | 34.38% | 43.94% | 59.59% | 74.89% | 61.23% | |||||
| Net Income Growth (1Y) | -0.54% | 2.16% | -11.10% | -11.04% | -3.93% | -0.90% | 45.55% | 37.36% | 25.35% | 21.49% | -0.55% | -15.01% | |||||
| EPS Growth (1Y) | -2.21% | 0.30% | -22.99% | -22.55% | -20.30% | -18.68% | 33.69% | 25.41% | 20.03% | 18.41% | -1.61% | -15.92% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -2.62 | -4.73 | -3.47 | -4.06 | -2.93 | -6.14 | -4.77 | -3.43 | -4.77 | -7.43 | -15.84 | -7.41 | |||||
| P/B TTM | 6.83 | 8.57 | 4.71 | 4.39 | 2.65 | 4.56 | 4.03 | 3.08 | 4.69 | 5.84 | 8.59 | 3.81 | |||||
| P/S TTM | 2.23 | 4.22 | 3.27 | 3.77 | 2.81 | 5.99 | 5.58 | 4.25 | 5.84 | 9.19 | 16.61 | 8.97 | |||||
| Market Cap | 136.29M | 249.32M | 185.20M | 211.18M | 153.30M | 316.46M | 286.29M | 200.72M | 259.33M | 386.63M | 652.52M | 315.56M | |||||
| Enterprise Value | 130.27M | 235.51M | 159.01M | 175.51M | 107.67M | 263.13M | 229.63M | 149.77M | 218.25M | 335.79M | 591.17M | 246.86M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -41.67M | -40.18M | -40.77M | -26.13M | -26.57M | -41.57M | -40.51M | -40.45M | -38.17M | -40.94M | -39.61M | -42.52M | |||||
| Net Debt | -6.02M | -13.81M | -26.19M | -35.67M | -45.63M | -53.34M | -56.66M | -50.95M | -41.08M | -50.85M | -61.35M | -68.70M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CVRx, Inc. (CVRX) — SEC Financial Statements & Analysis
CVRx, Inc. (CVRX) is a surgical & medical instruments & apparatus company, incorporated in DE. CVRx, Inc. trades on Nasdaq as: CVRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CVRx, Inc. reported a 11.96% year-over-year revenue growth, a Gross Profit Margin of 86.92% (TTM), a Debt-to-Equity ratio of 3.63x, a Price-to-Sales (P/S) ratio of 2.23x (TTM), a Price-to-Book (P/B) ratio of 6.83x (TTM), at a market cap of $136.29M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 11.96%
- Gross Profit Margin TTM
- 86.92%
- Debt To Equity
- 3.63x
- P/S TTM
- 2.23x
- P/B TTM
- 6.83x
- Market Cap
- $136.29M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CVRx, Inc. in?
CVRx, Inc. (CVRX) operates in the Surgical & Medical Instruments & Apparatus industry.
What is CVRX's market cap?
CVRx, Inc. (CVRX) has a market capitalization of $136.29M as of 2026-06-30.
What exchange does CVRX trade on?
CVRx, Inc. (CVRX) trades on the Nasdaq.
Where is CVRx, Inc. incorporated?
CVRx, Inc. is incorporated in DE.